Advance your academic career, collaborate globally, and expand your network— join now !

Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.

Michele Bernasconi

Share Link

Share

Information

Michele Bernasconi obtained a PhD in cell biology from the ETH Zurich. After a postdoctoral stay in the group of Prof. Tsujimoto at the National Children Hospital in Tokio with a postdoc fellowship from the Japanese Science and Technology Agency, in 2000 he joined the lab of Prof. Ruoslahti at the Burnham Research Institute in La Jolla, CA, with a postdoc fellowship of the Swiss National Science Foundation. From 2002 to 2020 he has been working on tumor targeting strategies for pediatric sarcomas at the University Children’s Hospital in Zurich. In 2015 he obtained the Venia Legendi for Experimental Pediatric Oncology at the Medical Faculty of the University of Zurich. Since 2018 he is Head of Research Lab at the Division of Pediatric Hematology and Oncology, University Hospital of Bern, and Research Manager Laboratory of the Children’s Research Center of the University Children’s Hospital Zurich. He is author of more than 30 peer-reviewed original research articles and one book chapter.

Research Keywords & Expertise

Liposomes
Targeted Drug Delivery
Tumor targeting
pediatric cancer
CAR T cells

Fingerprints

50%
Rhabdomyosarcoma
11%
targeting peptides
8%
Targeted Drug Delivery
8%
CAR T cells
6%
Liposomes
6%
Tumor targeting

Short Biography

Michele Bernasconi obtained a PhD in cell biology from the ETH Zurich. After a postdoctoral stay in the group of Prof. Tsujimoto at the National Children Hospital in Tokio with a postdoc fellowship from the Japanese Science and Technology Agency, in 2000 he joined the lab of Prof. Ruoslahti at the Burnham Research Institute in La Jolla, CA, with a postdoc fellowship of the Swiss National Science Foundation. From 2002 to 2020 he has been working on tumor targeting strategies for pediatric sarcomas at the University Children’s Hospital in Zurich. In 2015 he obtained the Venia Legendi for Experimental Pediatric Oncology at the Medical Faculty of the University of Zurich. Since 2018 he is Head of Research Lab at the Division of Pediatric Hematology and Oncology, University Hospital of Bern, and Research Manager Laboratory of the Children’s Research Center of the University Children’s Hospital Zurich. He is author of more than 30 peer-reviewed original research articles and one book chapter.